论文部分内容阅读
Ｓａｌｉｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌ公司的溃疡性肠炎治疗药巴柳氮二钠（ｂａｌｓａｌａｚｉｄｅ ｄｉｓｏｄｉｕｍ，Ｃｏｌａｚａｌ）获得美国ＦＤＡ许可，计划于２００１年第一季度上市。本品是美国１０年来第一个获得批准用于该适应证的新药。本品是５－氨基水杨酸（
Salix Pharmaceutical’s ulcerative colitis treatment, balsalazide disodium (Colazal), is FDA-licensed and scheduled for release in the first quarter of 2001. This product is the first new drug approved by the United States in 10 years for the indication. This product is 5-amino acid (